Top Markets
Coin of the day
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Classement en actions #25244
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Prix de l'action
$23.57
Dernière synchronisation: 2026-08-20
Capitalisation boursière
$51.76M
Changement (1 jour)
-0.08%
Changement (1 an)
289.59%
Pays
US
Échange Apollomics, Inc. (APLM)

Catégorie

Le prix APLM avec la capitalisation boursière de B
Apollomics, Inc. Apollomics, Inc.
APLM
$23.57
Capitalisation boursière de Apollomics, Inc.(APLM)
Capitalisation boursière: $51.76M
En August 2026, Apollomics, Inc. a une capitalisation boursière de $51.76M. Cela fait de Apollomics, Inc. la 25244th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Apollomics, Inc. du 2021 au 2026
APLM par rapport au top 5 des plus populaires stocks
Prix pour APLM L’actif B La capitalisation boursière de B Résultats
Apollomics, Inc. Apollomics, Inc.
$2,393,755 $51.76M
$5.257T +10,155,837.95%
Apollomics, Inc. Apollomics, Inc.
$2,094,038 $51.76M
$4.599T +8,884,234.11%
Apollomics, Inc. Apollomics, Inc.
$1,869,970 $51.76M
$4.107T +7,933,585.06%
Apollomics, Inc. Apollomics, Inc.
$1,628,934 $51.76M
$3.577T +6,910,950.02%
Apollomics, Inc. Apollomics, Inc.
$1,278,332 $51.76M
$2.807T +5,423,454.20%